Skip to content

The Effects of Including Almonds in a Weight Loss Trial

The Effects of Including Almonds in an Energy-restricted Diet on Weight, Abdominal Fat Loss, Blood Pressure, and Cognitive Function

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02360787
Enrollment
80
Registered
2015-02-11
Start date
2012-10-31
Completion date
2017-08-31
Last updated
2018-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overweight, Obesity

Keywords

Almonds, Energy restriction, Obesity, Body weight, Body fat, Blood pressure, Cognitive function

Brief summary

The purpose of this study is to determine whether inclusion of almonds in a weight loss regimen will augment the rate of weight loss, promote a greater fat mass/fat-free mass ratio of weight loss, improve blood pressure and ameliorate the post-lunch dip in cognitive function.

Detailed description

The purpose of this study is to determine whether inclusion of almonds in a weight loss regimen will augment the rate of weight loss, promote a greater fat mass/fat-free mass ratio of weight loss, improve blood pressure and ameliorate the post-lunch dip in cognitive function.

Interventions

BEHAVIORALAlmonds (15% kcal/day)

Sponsors

Almond Board of California
CollaboratorOTHER
Purdue University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

Adult participants * Overweight or obese (BMI 25-40 kg/m2) * Fasting blood glucose ≤6.9 mmol/L via capillary finger-stick blood samples * No nut allergies * Willing to comply to study protocol and to eat test meals

Exclusion criteria

Those not meeting inclusion criteria.

Design outcomes

Primary

MeasureTime frameDescription
Anthropometric measurements12 weeksChanges in body weight, BMI, fat mass, waist circumference and abdominal height over 12 weeks
Blood pressure12 weeksBlood pressure measurements assessed at baseline, week-4, week-8 and week-12
Post-lunch cognitive function12 weeksCognitive function assessments will be performed after a standard lunch at baseline and week 12

Secondary

MeasureTime frameDescription
Fasting blood biochemistries12 weeksFasting glucose, insulin, lipids and vitamin E over 12 weeks
Physical activity12 weeksPhysical activity assessed at baseline, week-4, week-8 and week-12
Dietary intake10 weeksDietary intakes assessed at baseline, week-1, week-2, week-3, week-4, week-6, week-8 and week-10
Appetite ratings12 weeksAppetite ratings assessed at baseline, week-4, week-8 and week-12

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 11, 2026